Search research articles
Contact Us
Filters
Showing results (11-20 of 30) with videos related to
Page
of 3
Sort By:
Journal of Lipid Research
|
February 23, 2012
Rescue of Mtp siRNA-induced hepatic steatosis by DGAT2 siRNA silencing
Samnang Tep, Radu Mihaila, Alexander Freeman, et al.
Scientific Reports
|
September 1, 2021
Phytosterol accumulation results in ventricular arrhythmia, impaired cardiac function and death in mice
Hongfei Ge, Gongxin Liu, Tracy M Yamawaki, et al.
Scientific Reports
|
June 5, 2021
Chamber-enriched gene expression profiles in failing human hearts with reduced ejection fraction
Xin Luo, Jun Yin, Denise Dwyer, et al.
Plos One
|
August 18, 2020
The evolving systemic biomarker milieu in obese ZSF1 rat model of human cardiometabolic syndrome: Characterization of the model and cardioprotective effect of GDF15
Marina Stolina, Xin Luo, Denise Dwyer, et al.
Lipids
|
August 10, 2011
ApoB siRNA-induced liver steatosis is resistant to clearance by the loss of fatty acid transport protein 5 (Fatp5)
Brandon Ason, Jose Castro-Perez, Samnang Tep, et al.
Molecular Therapy. Nucleic Acids
|
April 17, 2019
Modeling the Kinetics of Lipid-Nanoparticle- Mediated Delivery of Multiple siRNAs to Evaluate the Effect on Competition for Ago2
Radu Mihaila, Dipali Ruhela, Beverly Galinski, et al.
Molecular Pharmacology
|
March 24, 2011
RNA-induced silencing complex-bound small interfering RNA is a determinant of RNA interference-mediated gene silencing in mice
Jie Wei, Jeffrey Jones, Jing Kang, et al.
Nature Communications
|
October 10, 2025
Dissecting regulatory non-coding GWAS loci reveals fibroblast causal genes with pathophysiological relevance to heart failure
Richard Gill, Daniel R Lu, Ittai Eres, et al.
Journal of Lipid Research
|
September 27, 2014
PCSK9 inhibition fails to alter hepatic LDLR, circulating cholesterol, and atherosclerosis in the absence of ApoE
Brandon Ason, José W A van der Hoorn, Joyce Chan, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 6, 2015
Anti-PCSK9 antibody pharmacokinetics and low-density lipoprotein-cholesterol pharmacodynamics in nonhuman primates are antigen affinity-dependent and exhibit limited sensitivity to neonatal Fc receptor-binding enhancement
Kirk R Henne, Brandon Ason, Monique Howard, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 30) with videos related to
Sort By:
Page
of 3
Journal of Lipid Research
|
February 23, 2012
Rescue of Mtp siRNA-induced hepatic steatosis by DGAT2 siRNA silencing
Samnang Tep, Radu Mihaila, Alexander Freeman, et al.
Scientific Reports
|
September 1, 2021
Phytosterol accumulation results in ventricular arrhythmia, impaired cardiac function and death in mice
Hongfei Ge, Gongxin Liu, Tracy M Yamawaki, et al.
Scientific Reports
|
June 5, 2021
Chamber-enriched gene expression profiles in failing human hearts with reduced ejection fraction
Xin Luo, Jun Yin, Denise Dwyer, et al.
Plos One
|
August 18, 2020
The evolving systemic biomarker milieu in obese ZSF1 rat model of human cardiometabolic syndrome: Characterization of the model and cardioprotective effect of GDF15
Marina Stolina, Xin Luo, Denise Dwyer, et al.
Lipids
|
August 10, 2011
ApoB siRNA-induced liver steatosis is resistant to clearance by the loss of fatty acid transport protein 5 (Fatp5)
Brandon Ason, Jose Castro-Perez, Samnang Tep, et al.
Molecular Therapy. Nucleic Acids
|
April 17, 2019
Modeling the Kinetics of Lipid-Nanoparticle- Mediated Delivery of Multiple siRNAs to Evaluate the Effect on Competition for Ago2
Radu Mihaila, Dipali Ruhela, Beverly Galinski, et al.
Molecular Pharmacology
|
March 24, 2011
RNA-induced silencing complex-bound small interfering RNA is a determinant of RNA interference-mediated gene silencing in mice
Jie Wei, Jeffrey Jones, Jing Kang, et al.
Nature Communications
|
October 10, 2025
Dissecting regulatory non-coding GWAS loci reveals fibroblast causal genes with pathophysiological relevance to heart failure
Richard Gill, Daniel R Lu, Ittai Eres, et al.
Journal of Lipid Research
|
September 27, 2014
PCSK9 inhibition fails to alter hepatic LDLR, circulating cholesterol, and atherosclerosis in the absence of ApoE
Brandon Ason, José W A van der Hoorn, Joyce Chan, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 6, 2015
Anti-PCSK9 antibody pharmacokinetics and low-density lipoprotein-cholesterol pharmacodynamics in nonhuman primates are antigen affinity-dependent and exhibit limited sensitivity to neonatal Fc receptor-binding enhancement
Kirk R Henne, Brandon Ason, Monique Howard, et al.
Page
of 3